These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 4028280)
41. The germ-spectrum problem and antibiotic-resistance in Bida and Minna hospitals--Nigeria. Sixl W; Sixl B; Schneeweiss WD; Rosegger H; Schuhmann G; Reinthaler F; Mascher F; Haditsch M Geogr Med Suppl; 1989; 5():135-44. PubMed ID: 2599385 [TBL] [Abstract][Full Text] [Related]
42. [Pseudomonas spp from hospitals: typing and sensitivity to antibiotics]. Nazzari C; Mancini C; Brenciaglia MI; Giordano A; Cipriani P G Ital Chemioter; 1985; 32(1):203-6. PubMed ID: 3830779 [No Abstract] [Full Text] [Related]
44. [Multiresistance to antibiotics of bacteria of the genus Staphylococcus]. Andreoni S; Molinari GL; Farinetti F G Ital Chemioter; 1985; 32(1):195-8. PubMed ID: 3830778 [No Abstract] [Full Text] [Related]
45. [Bacteriological study on specimens from Department of Emergency and Critical Care Medicine (DECCM), Nippon Medical School. Staphylococcus aureus as viewed from the standpoint of hospital infection]. Ko MS; Satsuta K; Kurokawa A; Otsuka T Nihon Ika Daigaku Zasshi; 1985 Oct; 52(5):585-93. PubMed ID: 4066900 [No Abstract] [Full Text] [Related]
46. [Development of resistance to modern beta-lactam antibiotics]. Bakken JS; Sanders CC Tidsskr Nor Laegeforen; 1987 Apr; 107(12):1048-50. PubMed ID: 3603463 [No Abstract] [Full Text] [Related]
47. Is antimicrobial resistance in hospital microorganisms related to antibiotic use? McGowan JE Bull N Y Acad Med; 1987 Apr; 63(3):253-68. PubMed ID: 3300827 [No Abstract] [Full Text] [Related]
48. Lipovitellenin-lipase and deoxyribonuclease activities of hospital staphylococci. Fu SP; Mi ML; Shyu RJ; Jen TM Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Dec; 8(4):289-91. PubMed ID: 820525 [No Abstract] [Full Text] [Related]
54. [Epidemiology of drug resistance in pathogens isolated in hospitals]. Smolianskaya AZ Antibiot Khimioter; 1993 Jun; 38(6):62-6. PubMed ID: 8166570 [TBL] [Abstract][Full Text] [Related]
55. Stability of tobramycin in combination with selected new beta-lactam antibiotics. Elliott TS; Eley A; Cowlishaw A J Antimicrob Chemother; 1986 May; 17(5):680-1. PubMed ID: 3722037 [No Abstract] [Full Text] [Related]
56. Clinical use of the new beta-lactam antimicrobial drugs. Practical considerations for physicians, microbiology laboratories, pharmacists, and formulary committees. Brooks GF; Barriere SL Ann Intern Med; 1983 Apr; 98(4):530-5. PubMed ID: 6404207 [TBL] [Abstract][Full Text] [Related]
57. In vitro activity of five quinoline derivatives against nosocomial isolates of Staphylococcus and Pseudomonas species. Daschner FD; Just HM Eur J Clin Microbiol; 1985 Feb; 4(1):72-3. PubMed ID: 3987683 [No Abstract] [Full Text] [Related]
58. [The theoretical and practical aspects of the problem of antibiotic resistance]. Sidorenko SV Antibiot Khimioter; 1992 Sep; 37(9):44-7. PubMed ID: 1444672 [No Abstract] [Full Text] [Related]
59. Hospital infections from the WHO perspective. Velimirovic B Infect Control; 1983; 4(5):364-6. PubMed ID: 6556157 [No Abstract] [Full Text] [Related]
60. Resistance to beta-lactam antibacterial agents in hospitals. Gelmi M; Foresti I; Ravizzola G; Pirali F; Turano A Chemioterapia; 1985 Jun; 4(3):209-13. PubMed ID: 4028280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]